Carroll Financial Associates’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
FMI
DSA
Carroll Financial Associates's DGX Position: Q4 2021 in Review
Carroll Financial Associates reduced its Quest Diagnostics (DGX) stake by 0.57% in Q4 2021, selling an estimated $152 and leaving 175 shares worth $29K. The position accounts for ﹤0.01% of the portfolio, ranked #863.
Carroll Financial Associates first reported a position in DGX in Q4 2014 and has held it in 29 quarters since. The position peaked at $36K in Q4 2014. 906 funds tracked by Wall St. Rank hold DGX as of Q4 2021.
- Carroll Financial Associates held 175 shares of Quest Diagnostics worth $29K as of Q4 2021.
- Carroll Financial Associates sold 1 Quest Diagnostics share in Q4 2021, an estimated $152.
- Quest Diagnostics made up ﹤0.01% of Carroll Financial Associates's portfolio in Q4 2021, its #863 holding.
- Carroll Financial Associates first reported a position in Quest Diagnostics in Q4 2014 and has held it in 29 quarters since.
- Carroll Financial Associates's Quest Diagnostics position peaked at $36K in Q4 2014.
- 906 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2021.
Based on Carroll Financial Associates's 13F filing for Q4 2021, filed 6 Jan 2022.